THE 2012 APPELLATE HOT LIST

A standout performance by Wilmer Cutler

The National Law Journal

   | 0 Comments

Even by the standards of appellate powerhouse Wilmer Cutler Pickering Hale and Dorr, the second week of June in 2011 was a standout. The firm racked up victories in two closely watched patent cases before the U.S. Supreme Court. The first was on behalf of affiliates of pharmaceutical giant Roche Holding Ltd., which had been sued by Stanford University for infringing a patent for measuring the levels of HIV in a patient's blood. Days later, the Court ruled for i4i L.P., which had sued Microsoft Corp. for infringing its patent on a method for editing computer documents. In both cases, the Court upheld Federal Circuit rulings in favor of Wilmer clients.

This content has been archived. It is available exclusively through our partner LexisNexis®.

To view this content, please continue to Lexis Advance®.

Continue to Lexis Advance®

Not a Lexis Advance® Subscriber? Subscribe Now

Why am I seeing this?

LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via Lexis Advance®. This includes content from the National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at customercare@alm.com

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1202559509573

Thank you!

This article's comments will be reviewed.